Skip to main content
Premium Trial:

Request an Annual Quote

EGeen, Prediction Sciences Pen Pharmacogenomics Pact for Hypertension Drug Response

NEW YORK, Feb. 28 - EGeen International and Prediction Sciences plan to co-develop a diagnostic tool that can be used to help predict patient response to certain hypertension drugs.

Terms of the agreement call for Prediction Sciences to use its bioinformatics algorithms to compare patient chart information and SNP profiles with treatment outcomes. If successful, the collaboration will produce a tool that can be used in the clinic as "a predictive indicator of a patient's likelihood to respond to hypertension treatment."

Financial terms of the agreement were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.